Senturk, A. Et Al. 2016. Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.22, no.4 , 395-399.

Senturk, A., YILMAZEL UÇAR, E., BERK, S., ÖZLÜ, T., Altinsoy, B., Dabak, G., ... Cakir, E.(2016). Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.22, no.4, 395-399.

Senturk, Aysegul Et Al. "Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?," CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.22, no.4, 395-399, 2016

Senturk, Aysegul Et Al. "Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.22, no.4, pp.395-399, 2016

Senturk, A. Et Al. (2016) . "Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.22, no.4, pp.395-399.

@article{article, author={Aysegul Senturk Et Al. }, title={Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?}, journal={CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS}, year=2016, pages={395-399} }